Cargando…
Pedunculated Focal Nodular Hyperplasia: When in Doubt, Should We Cut It Out?
Focal nodular hyperplasia (FNH) is the second most common benign hepatic tumor and can rarely present as an exophytic solitary mass attached to the liver by a stalk. Most FNH cases are usually detected as incidental findings during surgery, imaging or physical examination and have a high female pred...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532121/ https://www.ncbi.nlm.nih.gov/pubmed/37762973 http://dx.doi.org/10.3390/jcm12186034 |
_version_ | 1785111881448423424 |
---|---|
author | Tsalikidis, Christos Mitsala, Athanasia Pappas-Gogos, George Romanidis, Konstantinos Tsaroucha, Alexandra K. Pitiakoudis, Michail |
author_facet | Tsalikidis, Christos Mitsala, Athanasia Pappas-Gogos, George Romanidis, Konstantinos Tsaroucha, Alexandra K. Pitiakoudis, Michail |
author_sort | Tsalikidis, Christos |
collection | PubMed |
description | Focal nodular hyperplasia (FNH) is the second most common benign hepatic tumor and can rarely present as an exophytic solitary mass attached to the liver by a stalk. Most FNH cases are usually detected as incidental findings during surgery, imaging or physical examination and have a high female predominance. However, the pedunculated forms of FNH are particularly rare and commonly associated with severe complications and diagnostic challenges. Hence, our study aims to provide a comprehensive summary of the available data on the pedunculated FNH cases among adults and children. Furthermore, we will highlight the role of different therapeutic options in treating this clinical entity. The use of imaging techniques is considered a significant addition to the diagnostic toolbox. Regarding the optimal treatment strategy, the main indications for surgery were the presence of symptoms, diagnostic uncertainty and increased risk of complications, based on the current literature. Herein, we also propose a management algorithm for patients with suspected FNH lesions. Therefore, a high index of suspicion and awareness of this pathology and its life-threatening complications, as an uncommon etiology of acute abdomen, is of utmost importance in order to achieve better clinical outcomes. |
format | Online Article Text |
id | pubmed-10532121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105321212023-09-28 Pedunculated Focal Nodular Hyperplasia: When in Doubt, Should We Cut It Out? Tsalikidis, Christos Mitsala, Athanasia Pappas-Gogos, George Romanidis, Konstantinos Tsaroucha, Alexandra K. Pitiakoudis, Michail J Clin Med Review Focal nodular hyperplasia (FNH) is the second most common benign hepatic tumor and can rarely present as an exophytic solitary mass attached to the liver by a stalk. Most FNH cases are usually detected as incidental findings during surgery, imaging or physical examination and have a high female predominance. However, the pedunculated forms of FNH are particularly rare and commonly associated with severe complications and diagnostic challenges. Hence, our study aims to provide a comprehensive summary of the available data on the pedunculated FNH cases among adults and children. Furthermore, we will highlight the role of different therapeutic options in treating this clinical entity. The use of imaging techniques is considered a significant addition to the diagnostic toolbox. Regarding the optimal treatment strategy, the main indications for surgery were the presence of symptoms, diagnostic uncertainty and increased risk of complications, based on the current literature. Herein, we also propose a management algorithm for patients with suspected FNH lesions. Therefore, a high index of suspicion and awareness of this pathology and its life-threatening complications, as an uncommon etiology of acute abdomen, is of utmost importance in order to achieve better clinical outcomes. MDPI 2023-09-18 /pmc/articles/PMC10532121/ /pubmed/37762973 http://dx.doi.org/10.3390/jcm12186034 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Tsalikidis, Christos Mitsala, Athanasia Pappas-Gogos, George Romanidis, Konstantinos Tsaroucha, Alexandra K. Pitiakoudis, Michail Pedunculated Focal Nodular Hyperplasia: When in Doubt, Should We Cut It Out? |
title | Pedunculated Focal Nodular Hyperplasia: When in Doubt, Should We Cut It Out? |
title_full | Pedunculated Focal Nodular Hyperplasia: When in Doubt, Should We Cut It Out? |
title_fullStr | Pedunculated Focal Nodular Hyperplasia: When in Doubt, Should We Cut It Out? |
title_full_unstemmed | Pedunculated Focal Nodular Hyperplasia: When in Doubt, Should We Cut It Out? |
title_short | Pedunculated Focal Nodular Hyperplasia: When in Doubt, Should We Cut It Out? |
title_sort | pedunculated focal nodular hyperplasia: when in doubt, should we cut it out? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532121/ https://www.ncbi.nlm.nih.gov/pubmed/37762973 http://dx.doi.org/10.3390/jcm12186034 |
work_keys_str_mv | AT tsalikidischristos pedunculatedfocalnodularhyperplasiawhenindoubtshouldwecutitout AT mitsalaathanasia pedunculatedfocalnodularhyperplasiawhenindoubtshouldwecutitout AT pappasgogosgeorge pedunculatedfocalnodularhyperplasiawhenindoubtshouldwecutitout AT romanidiskonstantinos pedunculatedfocalnodularhyperplasiawhenindoubtshouldwecutitout AT tsarouchaalexandrak pedunculatedfocalnodularhyperplasiawhenindoubtshouldwecutitout AT pitiakoudismichail pedunculatedfocalnodularhyperplasiawhenindoubtshouldwecutitout |